Table of Contents
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Implantable Cardioverter Defibrillators (ICD) Overview 7
3 Products under Development 8
3.1 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 8
3.2 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment 9
3.3 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory 10
3.4 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path 11
3.5 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date 12
3.6 Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials 13
4 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products under Development by Companies 14
4.1 Implantable Cardioverter Defibrillators (ICD) Companies – Pipeline Products by Stage of Development 14
4.2 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 15
5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview 16
5.1 AIS Inc. Company Overview 16
5.1.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Boston Scientific Corp Company Overview 17
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 CardiaLen, Inc. Company Overview 25
5.3.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 Coridea, LLC Company Overview 28
5.4.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.5 InnerPulse Inc (Inactive) Company Overview 29
5.5.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 Johns Hopkins University Company Overview 30
5.6.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Kenergy Inc. Company Overview 31
5.7.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 Massachusetts General Hospital Company Overview 32
5.8.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 32
5.9 Max Planck Institute for Dynamics and Self-Organization Company Overview 33
5.9.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 33
5.10 Medtronic plc Company Overview 34
5.10.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34
5.11 MicroPort CRM Company Overview 39
5.11.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview 39
5.12 Smartwave Medical Ltd (Inactive) Company Overview 46
5.12.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46
6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments 47
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 47
6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 49
6.3 Oct 30, 2019: CONMED announces third quarter 2019 financial results 50
6.4 Oct 28, 2019: Philips delivers Q3 sales of EUR 4.7 billion, with 6% comparable sales growth, EUR 211 million income from continuing operations and an Adjusted EBITA margin of 12.4% 51
6.5 Oct 28, 2019: Philips’ third quarter results 2019 53
7 Appendix 107
7.1 Methodology 107
7.2 About GlobalData 110
7.3 Contact Us 110
7.4 Disclaimer 110
Table 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
Table 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
Table 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
Table 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
Table 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
Table 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
Table 7: Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
Table 8: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
Table 9: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Guardian - Product Status
Table 11: Guardian - Product Description
Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 13: EMBLEM MRI S-ICD System - Aged Patients - Product Status
Table 14: EMBLEM MRI S-ICD System - Aged Patients - Product Description
Table 15: S-ICD System 1.5 - Product Status
Table 16: S-ICD System 1.5 - Product Description
Table 17: S-ICD System 2.0 - Product Status
Table 18: S-ICD System 2.0 - Product Description
Table 19: VITALITY NXT Defibrillator - Product Status
Table 20: VITALITY NXT Defibrillator - Product Description
Table 21: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 22: S-ICD System 2.0 - A Prospective Randomised Comparative Trial of Subcutaneous Implantable Cardioverter-defibrillator Implantation with and without Defibrillation Testing
Table 23: S-ICD System 1.5 - A Prospective Randomised Comparative Trial of Subcutaneous Implantable Cardioverter-defibrillator Implantation with and without Defibrillation Testing
Table 24: EMBLEM MRI S-ICD System - Aged Patients - Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD)
Table 25: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 26: CardiaLen Device - Atrial Fibrillation - Product Status
Table 27: CardiaLen Device - Atrial Fibrillation - Product Description
Table 28: CardiaLen, Inc. - Ongoing Clinical Trials Overview
Table 29: CardiaLen Device - Atrial Fibrillation - An International Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Unpinning Termination Therapy in Patients with VT/VF
Table 30: CardiaLen Device - Atrial Fibrillation - Unpinning Pulse Termination Therapy for Ventricular Tachyarrhythmias
Table 31: Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Table-Top PaDe System - Product Status
Table 33: Table-Top PaDe System - Product Description
Table 34: InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 35: PICD - Product Status
Table 36: PICD - Product Description
Table 37: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Cardiac Sock Electrode And Implantable Defibrillator System - Product Status
Table 39: Cardiac Sock Electrode And Implantable Defibrillator System - Product Description
Table 40: Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Unconditional MRI Compatible Implantable Defibrillator - Product Status
Table 42: Unconditional MRI Compatible Implantable Defibrillator - Product Description
Table 43: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Implantable Cardioverter Defibrillator - Ventricular Arrhythmias - Product Status
Table 45: Implantable Cardioverter Defibrillator - Ventricular Arrhythmias - Product Description
Table 46: Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Implantable Defibrillator - Product Status
Table 48: Implantable Defibrillator - Product Description
Table 49: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Chronicle ICD - Product Status
Table 51: Chronicle ICD - Product Description
Table 52: EV-ICD System - Product Status
Table 53: EV-ICD System - Product Description
Table 54: Medtronic plc - Ongoing Clinical Trials Overview
Table 55: Chronicle ICD - Benefits of ICD for the Primary Prevention in Patients with Valvular Cardiomyopathy
Table 56: EV-ICD System - Benefits of ICD for the Primary Prevention in Patients with Valvular Cardiomyopathy
Table 57: EV-ICD System - Extravascular ICD Pilot Study
Table 58: EV-ICD System - Extravascular ICD Pivotal Study (EV ICD)
Table 59: MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
Table 60: NAVIGO 4LV 2D - Product Status
Table 61: NAVIGO 4LV 2D - Product Description
Table 62: NAVIGO 4LV ARC - Product Status
Table 63: NAVIGO 4LV ARC - Product Description
Table 64: NAVIGO 4LV PILOT - Product Status
Table 65: NAVIGO 4LV PILOT - Product Description
Table 66: MicroPort CRM - Ongoing Clinical Trials Overview
Table 67: NAVIGO 4LV 2D - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
Table 68: NAVIGO 4LV ARC - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
Table 69: NAVIGO 4LV PILOT - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
Table 70: Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Fully Automatic Implantable Atrial Defibrillator - Product Status
Table 72: Fully Automatic Implantable Atrial Defibrillator - Product Description
Table 73: Glossary
List of Figures
Figure 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
Figure 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
Figure 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
Figure 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
Figure 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
Figure 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
【免責事項】
https://www.marketreport.jp/reports-disclaimer
